- £184.66m
- £247.64m
- £279.60m
Holding(s) in Company
Annual Report and Notice of Annual General Meeting
Director/PDMR Shareholding
Director/PDMR Shareholding
Brief: Stelrad Says Trading For Period End Remaining In Line With Expectations
Preliminary announcement of final results
Director/PDMR Shareholding
Brief: Stelrad Group Expects To Deliver Adj Operating Profit Of C. £31.5M For FY
Trading Update
Director/PDMR Shareholding
Brief: Stelrad Group Maintains FY24 Guidance
Trading Update and Capital Markets Event
Brief: Stelrad Group Appoints Leigh Wilcox As CFO
Directorate Change
Holding(s) in Company
Director Declaration
Europe Research Roundup: AstraZeneca, Beazley, Puma
Brief: Stelrad Group HY Adjusted Operating Profit Rises
Brief: Stelrad H1 Adjusted Net Income GBP 8.1 Mln